期刊文献+

桡动脉与股动脉入路在行冠状动脉介入术的疗效评价 被引量:1

Comparison of therapeutic effects of trans-radial and trans-femoral coronary
下载PDF
导出
摘要 目的探讨和比较经桡动脉途径和股动脉途径行冠状动脉介入治疗的疗效。方法选择2009年10月至2012年10月在我院住院的100例冠心病患者,根据穿刺入路把患者分为桡动脉组和股动脉组,每组各50例,评价两组患者的穿刺时间、住院时间以及术后并发症等。结果与股动脉组相比,桡动脉组的穿刺时间、住院卧床时间明显缩短,P<0.05。且桡动脉组术后出现并发症的发生率明显降低,P<0.05,两组冠状动脉介入诊疗时间无明显差别。结论相对于股动脉入路,经桡动脉行冠状动脉介入治疗的术后并发症相对较少,并且住院时间较短,从而增加了患者的耐受性和依从性。 Objective To explore and discuss the therapeutic effects of trans-radial and trans-femoral coronary interven tion.Methods One hundred patients with coronary heart disease from October 2009 to October 2012 admitted to our hospital were di vided into trans-radial group and trans-femoral group according to puncture way,with 50 cases in each group.The puncture time,hospitalization time,postoperative complications and other aspects of the two groups were observed and compared.Results Compared with trans-femoral group,the puncture time and therapeutic operation time and hospitalization time of trans-radial group were significantly sHorter(P&lt; 0.05).Compared with trans-femoral group,the incidence of postoperative complications of trans-radial group was significantly decreased(P&lt; 0.05).There was no statistically significant difference of consultation time of coronary intervention between the twogroups.Conclusion Relative to the way of trans-femoral,the treatment of trans-radial coronary intervention has less postoperative complications,sorter hospitalization time,which adds comfort of patients and easier to be accepted by the patients and families.
作者 张春震 赵郁
出处 《中国实用医药》 2013年第14期17-19,共3页 China Practical Medicine
关键词 桡动脉 股动脉 急性冠脉综合征 冠状动脉介入治疗 Radial artery Femoral artery Coronary heart disease Coronary intervention
  • 相关文献

参考文献5

二级参考文献27

  • 1CHANCE研究组.无保护左主干病变支架置入术预后及影响因素的分析——中国无保护左主干病变支架置入术注册(CHANCE)研究[J].中华心血管病杂志,2005,33(3):210-215. 被引量:19
  • 2李海燕,李晓霞,马丹丹.两种路径行冠状动脉造影术后患者舒适度和局部并发症的对比[J].护理学报,2006,13(2):6-8. 被引量:21
  • 3Eric L Eisenstein, DBA,Kevin J. Anstrom, PhD,David F. Kong, MD,Linda K. Shaw, MS,Robert H. Tuttle, MSPH,Daniel B. Mark, MD, MPH,Judith M. Kramer, MD, MS,Robert A. Harrington, MD,David B. Matchar, MD,David E. Kandzari, MD 1,Eric D. Peterson, MD, MPH,Kevin A. Schulman, MD,Robert M. Califf, MD,李呈亿(译),David E. Kandzari, MD.氯吡格雷的使用与药物洗脱支架植入后远期临床结果[J].美国医学会杂志(中文版),2007,26(3):131-139. 被引量:59
  • 4魏盟 严卫 樊冰 等.经皮穿刺桡动脉冠状动脉造影及冠状动脉成形术[J].Chinese Medical Journal(中华医学杂志:英文版),2000,113:24-25.
  • 5Kim JY, Yoon J, Jung HS, et al. Feasibility of the radial artery as a vascular access route in performing primary percutaneous coronary intervertion [J].Yonsei Med J, 2005, 46 (4): 503-510.
  • 6Archbold RA, Robinson NM, Schilling RJ. Radial artery access for coronary angiography and percutaneous coronary intervertion [J]. BMJ, 2004, 329 (7463): 443-446.
  • 7Ziakas A, Klinke P, Mildenberger R, et al. Comparison of the radial and the femoral approaches in percutaneous coronary intervertion for acute myocardial infarction [J]. Am J Cardiol, 2003, 91 (5): 598-600.
  • 8Cantor WJ, Puley G, Natarajan MK, et al. Radial versus femoral access for emergent percutaneous coronary intervertion with adjunct glycoprotein IIb/IIIa inhibition in acute myocardial infarction- the RADIAL-AMI pilot randomized trial[J]. Am Heart J, 2005, 150 (3): 543-549.
  • 9Shishehbor MH, Lauer MS, Singh IM, et al. In unstable angina or non-ST-segment acute coronary syndrome, should patients with multivessel coronary artery disease undergo multivessel or culprit-only stenting[J]. J Am Coil Cardiai, 2007, 49 (8):849-854.
  • 10Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery ( EACTS ), European Association for Percutaneous Cardiovascular Interventions (EAPCI), Wijns W, et al. Guidelines on myocardial revascularization. Eur Heart J,2010 , 31:2501-2555.

共引文献1058

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部